• Markets
    • icon
  • Companies
BOD · ASX

Bod Science Limited (ASX:BOD)

AU$0.024

 0.0 (0.0%)
ASX:Live
27/11/2023 12:00:00 AM
Near Support Near 52 Week Low HALO Ords GROWTH AUS Big Candle +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BOD Overview

BOD Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About BOD

Website

Bod Science Limited

Telephone

61.2.9199.5018

Address

Level 2 376 New South Head Road Double Bay, New South Wales (NSW) 2028

Description

Bod Science Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. It operates through the following segments: OTC Medical, OTC CBD/Hemp, and Herbals. The company was founded by Joanne Patterson on August 13, 2014 and is headquartered in Double Bay, Australia.

BOD Price Chart

Key Stats

Market Cap

AU$4.26M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.17

Trade Value (12mth)

AU$3,384.00

1 week

-7.69%

1 month

-52%

YTD

-83.45%

1 year

-84%

All time high

0.730166

Key Fundamentals

EPS 3 yr Growth

5.600%

EBITDA Margin

-536.70%

Operating Cashflow

-$6m

Free Cash Flow Return

-410.90%

ROIC

-575.60%

Interest Coverage

-337.20

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

153m

HALO Sector

Staples

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BOD Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities Report

×

Quarterly Activities Report

31 October 23

Appendix 4C

×

Appendix 4C

31 July 23

Quarterly Activities Report

×

Quarterly Activities Report

31 July 23

Appendix 4C

×

Appendix 4C

31 January 23

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

31 January 22

Quarterly Activities Report and Quarterly Cash Flow Report

×

Quarterly Activities Report and Quarterly Cash Flow Report

31 August 23

Notice of Extraordinary General Meeting

×

Notice of Extraordinary General Meeting

30 September 22

Application for quotation of securities - BOD

×

Application for quotation of securities - BOD

30 October 23

Grant of ASX waiver regarding Aqua Phase acquisition

×

Grant of ASX waiver regarding Aqua Phase acquisition

30 June 23

Bod announces progress in Aqua Phase PK Studies

×

Bod announces progress in Aqua Phase PK Studies

30 August 23

FY23 Appendix 4E and Financial Statements

×

FY23 Appendix 4E and Financial Statements

30 August 22

Trading Halt

×

Trading Halt

30 August 22

Bod to acquire Aqua Phase

×

Bod to acquire Aqua Phase

30 August 22

Appendix 4E and full year statutory accounts

×

Appendix 4E and full year statutory accounts

29 October 21

Annual Report to shareholders

×

Annual Report to shareholders

29 April 22

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

28 October 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

28 October 22

Annual Report to shareholders

×

Annual Report to shareholders

28 November 23

Suspension from Quotation

×

Suspension from Quotation

28 November 22

Chief Executive Officer presentation to the 2022 AGM

×

Chief Executive Officer presentation to the 2022 AGM

28 November 22

Results of Annual General Meeting

×

Results of Annual General Meeting

28 March 23

Aqua Phase PK Study submitted for ethics approval

×

Aqua Phase PK Study submitted for ethics approval

28 July 22

Quarterly activities report and Appendix 4C

×

Quarterly activities report and Appendix 4C

28 April 23

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

27 September 23

Aqua Phase CBD PK Study Results

×

Aqua Phase CBD PK Study Results

27 October 22

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

27 November 23

Results of Meeting

×

Results of Meeting

BOD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.05 -0.06 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.05 -0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.0 -19.7 -11.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.05 -0.05 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.04 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.4 -43.6 0.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -17.6 -56.6 -58.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.08 0.03 -0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.08 0.03 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 64.7 -63.3 -119.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 100 107 141 Lock Lock Lock
Basic m Lock Lock Lock Lock 100 107 141 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 7 4 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.9 -45.8 -52.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 4 7 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.2 -309.3 -3.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -10.9 -82.2 -179.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 111 182 279 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -5 -7 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.5 -39.3 -33.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -74.9 -192.5 -536.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -7 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.2 -38.7 -32.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -76.9 -196.8 -546.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -7 -9 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -5 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.3 -27.9 -47.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -63.6 -150.1 -462.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -6 -4 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 8 0 4 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -4 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -80.3 28.3 -37.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.9 -1.2 -3.3 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 8 4 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 10 5 4 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -8 -4 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 9 3 -1 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 9 3 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 80.2 -60.0 -120.3 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -40.8 -101.8 -227.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -48.8 -156.0 1,130.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -75.9 -116.9 -504.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -62.8 -89.2 -575.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -86.6 -68.9 -410.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -337.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.6 0.5 0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.0 -105.7 151.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.9 2.7 0.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.7 2.4 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 80.7 75.1 61.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -344.9 -234.2 -156.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.0 6.2 4.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 16.7 13.6 11.4 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.8 1.2 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.1 31.9 83.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -75.1 -187.3 -541.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -48.2 -126.9 -265.7 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -40.8 -101.8 -227.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.5 -5.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -48.8 -156.0 1,130.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -48.8 -156.0 1,130.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 21.9 26.8 32.2 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 60.9 58.6 87.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 82.8 85.4 119.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 69.0 51.3 104.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 13.8 34.0 15.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BOD Shortsell

Frequently Asked Questions

The current share price of Bod Science Limited (BOD:ASX) is AU$0.024.
The 52-week high share price for Bod Science Limited (BOD:ASX) is AU$0.17.
The 52-week low share price for Bod Science Limited (BOD:ASX)? is AU$0.02.
Bod Science Limited (BOD:ASX) does not pay a dividend.
Bod Science Limited (BOD:ASX) does not pay a dividend.
Bod Science Limited (BOD:ASX) does not offer franking credits.
Bod Science Limited (BOD:ASX) is classified in the Staples.
The current P/E ratio for Bod Science Limited (BOD:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.